Patient safety data as assessed by adjusted OR by cytoreductive therapy
| . | HU . | Non-ropeg interferons . | Ropeg . | Rux . | Phlebotomy . | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| OR . | SE . | 95% CI . | P value . | OR . | SE . | 95% CI . | P value . | OR . | SE . | 95% CI . | P value . | OR . | SE . | 95% CI . | P value . | ||
| Anemia | 1.41 | 1.10 | (1.16-1.71) | .0006 | 1.10 | 1.56 | (0.46-2.64) | .823 | 0.70 | 1.32 | (0.41-1.22) | .2092 | 1.53 | 1.15 | (1.18-2.00) | .0016 | Ref |
| Cytopenia | 1.72 | 1.1 | (1.44-2.06) | <.0001 | 1.68 | 1.75 | (0.56-5.00) | .3521 | 1.18 | 1.41 | (0.61-2.30) | .6248 | 1.22 | 1.15 | (0.94-1.59) | .1424 | Ref |
| Cytopenia (with or without anemia) | 2.36 | 1.12 | (1.89-2.94) | <.0001 | 2.82 | 1.67 | (1.03-7.67) | .043 | 1.11 | 1.51 | (0.49-2.49) | .8003 | 0.82 | 1.14 | (0.63-1.06) | .1262 | Ref |
| Cardiac | 0.89 | 1.13 | (0.69-1.13) | .3267 | 0.38 | 1.29 | (0.23-0.62) | .0001 | 0.25 | 1.8 | (0.08-0.79) | .0178 | 0.97 | 1.15 | (0.73-1.27) | .8077 | Ref |
| CNS/mood | 0.91 | 1.13 | (0.71-1.16) | .4509 | 0.92 | 1.62 | (0.36-2.37) | .868 | 0.66 | 1.67 | (0.24-1.81) | .4185 | 0.99 | 1.16 | (0.75-1.32) | .9515 | Ref |
| GI | 1.05 | 1.22 | (0.71-1.56) | .8033 | 0.81 | 2.07 | (0.19-3.38) | .7745 | 0.84 | 2.63 | (0.13-5.60) | .8583 | 0.87 | 1.25 | (0.56-1.35) | .537 | Ref |
| DVT/PE | 0.98 | 1.24 | (0.64-1.49) | .9272 | 0.98 | 1.78 | (0.32-3.03) | .977 | 0.57 | 1.17 | (0.42-0.78) | .0004 | 1.37 | 1.35 | (0.77-2.46) | .2842 | Ref |
| Respiratory | 1.39 | 1.33 | (0.79-2.44) | .2525 | 0.14 | 2.36 | (0.03-0.78) | .0243 | 0.96 | 3.14 | (0.10-9.04) | .9733 | 1.28 | 1.32 | (0.74-2.21) | .3706 | Ref |
| Skin disorder | 0.76 | 1.91 | (0.21-2.70) | .6663 | 0.55 | 2.92 | (0.07-4.50) | .5774 | 0.34 | 2.11 | (0.08-1.47) | .1484 | 0.42 | 1.91 | (0.12-1.50) | .1825 | Ref |
| . | HU . | Non-ropeg interferons . | Ropeg . | Rux . | Phlebotomy . | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| OR . | SE . | 95% CI . | P value . | OR . | SE . | 95% CI . | P value . | OR . | SE . | 95% CI . | P value . | OR . | SE . | 95% CI . | P value . | ||
| Anemia | 1.41 | 1.10 | (1.16-1.71) | .0006 | 1.10 | 1.56 | (0.46-2.64) | .823 | 0.70 | 1.32 | (0.41-1.22) | .2092 | 1.53 | 1.15 | (1.18-2.00) | .0016 | Ref |
| Cytopenia | 1.72 | 1.1 | (1.44-2.06) | <.0001 | 1.68 | 1.75 | (0.56-5.00) | .3521 | 1.18 | 1.41 | (0.61-2.30) | .6248 | 1.22 | 1.15 | (0.94-1.59) | .1424 | Ref |
| Cytopenia (with or without anemia) | 2.36 | 1.12 | (1.89-2.94) | <.0001 | 2.82 | 1.67 | (1.03-7.67) | .043 | 1.11 | 1.51 | (0.49-2.49) | .8003 | 0.82 | 1.14 | (0.63-1.06) | .1262 | Ref |
| Cardiac | 0.89 | 1.13 | (0.69-1.13) | .3267 | 0.38 | 1.29 | (0.23-0.62) | .0001 | 0.25 | 1.8 | (0.08-0.79) | .0178 | 0.97 | 1.15 | (0.73-1.27) | .8077 | Ref |
| CNS/mood | 0.91 | 1.13 | (0.71-1.16) | .4509 | 0.92 | 1.62 | (0.36-2.37) | .868 | 0.66 | 1.67 | (0.24-1.81) | .4185 | 0.99 | 1.16 | (0.75-1.32) | .9515 | Ref |
| GI | 1.05 | 1.22 | (0.71-1.56) | .8033 | 0.81 | 2.07 | (0.19-3.38) | .7745 | 0.84 | 2.63 | (0.13-5.60) | .8583 | 0.87 | 1.25 | (0.56-1.35) | .537 | Ref |
| DVT/PE | 0.98 | 1.24 | (0.64-1.49) | .9272 | 0.98 | 1.78 | (0.32-3.03) | .977 | 0.57 | 1.17 | (0.42-0.78) | .0004 | 1.37 | 1.35 | (0.77-2.46) | .2842 | Ref |
| Respiratory | 1.39 | 1.33 | (0.79-2.44) | .2525 | 0.14 | 2.36 | (0.03-0.78) | .0243 | 0.96 | 3.14 | (0.10-9.04) | .9733 | 1.28 | 1.32 | (0.74-2.21) | .3706 | Ref |
| Skin disorder | 0.76 | 1.91 | (0.21-2.70) | .6663 | 0.55 | 2.92 | (0.07-4.50) | .5774 | 0.34 | 2.11 | (0.08-1.47) | .1484 | 0.42 | 1.91 | (0.12-1.50) | .1825 | Ref |
CNS, central nervous system; DVT, deep vein thrombosis; GI, gastrointestinal events; PE, pulmonary embolism; Ref, ref; SE, standard error.